Yuanbao (YB.US) releases Q1 2026 financial report: Upgrading the insurance service value chain from "Toolized AI" to "Organized AI"

Recently, leading insurance technology company YB.US released its unaudited financial performance for the first quarter of 2026. As one of the representatives of insurance technology companies listed on the US stock market, YB continues to drive steady growth with AI technology. Data shows that YB's first-quarter revenue reached 1.316 billion RMB, an increase of 35.6% year-on-year; net profit continued its steady performance from the previous quarter, and operational stability was fully verified. As of March 31, 2026, YB's model matrix has expanded to over 5000 models, with more than 5800 features, representing an increase of approximately 250 models and 700 features year-on-year. On the technical side, YB has built a structured knowledge system covering product terms, underwriting rules, and service processes, based on its insurance expertise knowledge base and domain modeling capabilities, with millions of professional knowledge data entries. With the above capabilities, YB has launched insurance consulting and planning applications for consumers, providing services such as product guarantee interpretation, assistance in insuring pre-existing conditions, insurance plan planning, and comparing policy explanations, achieving personalized insurance consultation and planning. In terms of technology strategy, YB relies on a three-tier architecture of "base + skills + scenarios" to accelerate the transition from "tool-based AI" to "organizational AI", injecting strong momentum into operational efficiency improvement and user experience enhancement. Currently, the "14th Five-Year Plan" explicitly promotes "artificial intelligence +", and policies related to the high-quality development of commercial health insurance are being introduced in quick succession. The first edition of the list of innovative drugs covered by commercial insurance has been implemented, combined with DRG/DIP payment reform driving the integration of commercial insurance and medical insurance. The "insurance + service" ecosystem has become the mainstream trend, and the insurance industry has entered a new stage of structural optimization and value cultivation. YB is following the trend and leading the way. On the product side, YB continues to iterate inclusive products in collaboration with insurance companies, accurately covering subgroups such as people with pre-existing conditions and new urban residents, promptly incorporating the list of innovative drugs covered by commercial insurance into its products, closely following new industry policy trends to meet the public's demand for cutting-edge therapies and quality medications. On the service side, YB deeply integrates technological capabilities into the entire claims process and has launched the "smart claims assistance" function to assist insurance companies in conducting initial assessments on small and low-risk cases. Leveraging its self-developed claims review system, YB enhances the efficiency of insurance company claims processing and optimizes user claims experience, significantly improving the timeliness of responding to small claims. According to public information, YB went public on the NASDAQ in the United States in April 2025. With its industry-leading innovation practices and brand influence, YB has been successfully selected for the "2025 Forbes China Business Brand Management Influence Evaluation" list and the "2026 China Listed Companies Brand Value List" annual Emerging Power List TOP50, making it the only insurance technology company selected in the evaluations. YB's two major AI applications, intelligent customer service and intelligent claims, have also been included in the Tsinghua Wudaokou "AI Insurance Industry Application Innovation White Paper", and its technological exploration of "AI + Insurance" has been recognized by authoritative research institutions.